Hemoperfusion is described as an extracorporeal form of treatment because the blood is pumped through a device outside the patient's body. This method was introduced in 1965 as a method for removing toxic substances from the body. It is done by lowering the blood concentration of several xenobiotic agents when they are the cause of intoxication. Adsorption is a method in which molecules or particles of one substance are attracted to the surface of solid material and held on there. These solid materials are called sorbents. In hemoperfusion, whole blood is passed through a column that contains fixed adsorbent particles. Toxins with molecular weights ranging from 100 to 40,000 Daltons bind to the particles and are removed as blood exits the column. Higher-molecular-weight solutes are adsorbed less efficiently. The sorbents most commonly used in hemoperfusion are resins and various forms of activated carbon or charcoal.
MARKET DYNAMICS
The rising number of blood and blood-related disorders and increasing use of adsorbent substance techniques to remove toxic substances and poisons will spur the demand of the hemoperfusion market. Fluctuations in the price of the upstream product such as the major raw materials polypropylene, polycarbonate, membrane materials, activated carbon, etc. used in hemoperfusion will impact on the production cost of hemoperfusion. Hence, it will affect the price of hemoperfusion, which could affect the market value of the hemoperfusion market. Hemoperfusion manufacturers are trying to produce many more types of hemoperfusion for other different diseases. However, the risks of infection, blood clotting, destruction of blood platelets, and organ failure associated with hemoperfusion may restrict the adoption of this technology that may hinder the growth of the market in the forecasted period.
MARKET SCOPE
The "Global Hemoperfusion Market Analysis to 2028" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of hemoperfusion market with detailed market segmentation by product, application, and geography. The global hemoperfusion Market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading hemoperfusion market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global hemoperfusion market is segmented on the product, and application. Based on product, the global hemoperfusion market is segmented into charcoal hemoperfusion, certain resins hemoperfusion, and polymer hemoperfusion. Based on the application, the hemoperfusion market is segmented hepatic encephalopathy, overdose, specific intoxications, certain autoimmune diseases, and other.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global hemoperfusion market based on various segments. It also provides market size and forecast estimates from year 2019 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The hemoperfusion market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting hemoperfusion market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the hemoperfusion market in these regions.
MARKET PLAYERS
The reports cover key developments in the hemoperfusion market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from hemoperfusion market are anticipated to lucrative growth opportunities in the future with the rising demand for hemoperfusion in the global market. Below mentioned is the list of few companies engaged in the hemoperfusion market.
The report also includes the profiles of key hemoperfusion market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Baxter
- Asahi Kasei Medical Co., Ltd.
- TORAY MEDICAL CO,.LTD.
- Biosun Corporation
- Jafron Biomedical Co.
- Kaneka Pharma
- CytoSorbents Corporation
- Medtronic
- Fresenius SE & Co. KGaA
- B. Braun Melsungen AG
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.